Submissions
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.- The submission has not been previously published, nor it is in consideration in another journal.
- The submission file is in Microsoft Word, RTF, or WordPerfect document file format.
-
The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses), tables are placed within text at the appropriate points and all illustrations and figures must be separately uploaded within "Upload Other Files" section.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
- We strongly suggest you use our MS Word template for submission.
Author Guidelines
The editorial policy
Radiology and Oncology is a multidisciplinary journal devoted to the publishing original and high-quality scientific papers and review articles, pertinent to oncologic imaging, interventional radiology, nuclear medicine, radiotherapy, clinical and experimental oncology, radiobiology, medical physics, and radiation protection. Papers on more general aspects of interest to the radiologists and oncologists are also published (no case reports).
The Editorial Board requires that the paper has not been published or submitted for publication
elsewhere; the authors are responsible for all statements in their papers. Accepted cannot be published elsewhere without the written permission of the editors.
Submission of the manuscript
The manuscript written in English should be submitted to the journal via online submission system Editorial Manager available for this journal at: www.radioloncol.com.
In case of problems, please contact Sašo Trupej at saso.trupej@computing.si or the Editor of this journal at gsersa@onko-i.si
All articles are subjected to the editorial review and when the articles are appropriated they are reviewed by independent referees. In the cover letter, which must accompany the article, the authors are requested to suggest 3-4 researchers, competent to review their manuscript. However, please note that this will be treated only as a suggestion; the final selection of reviewers is exclusively the Editor’s decision. The authors’ names are revealed to the referees, but not vice versa.
Manuscripts which do not comply with the technical requirements stated herein will be returned to the authors for the correction before peer-review. The editorial board reserves the right to ask authors to make appropriate changes of the contents as well as grammatical and stylistic corrections when necessary. Page charges will be charged for manuscripts exceeding the recommended length, as well as additional editorial work and requests for printed reprints.
Articles are published printed and on-line as the open access:
(https://content.sciendo.com/raon).
All articles are subject to 1500 EUR + VAT publication fee. Exceptionally, waiver of payment may be negotiated with editorial office, at the time of article submission.
Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission and are responsible for its content; they must have agreed to its publication and have given the corresponding author the authority to act on their behalf in all matters pertaining to publication. The corresponding author is responsible for informing the co-authors of the manuscript status throughout the submission, review, and production process.
Preparation of manuscripts
Radiology and Oncology will consider manuscripts prepared according to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by International Committee of Medical Journal Editors (www.icmje.org). The manuscript should be written in grammatically and stylistically correct language. Abbreviations should be avoided. If their use is necessary, they should be explained at the first time mentioned. The technical data should conform to the SI system. The manuscript, excluding the references, tables, figures and figure legends, must not exceed 5000 words, and the number of figures and tables is limited to 8. Organize the text so that it includes: Introduction, Materials and methods, Results and Discussion. Exceptionally, the results and discussion can be combined in a single section. Start each section on a new page, and number each page consecutively with Arabic numerals. For ease of review, manuscripts should be submitted as a single column, double-spaced text. The template for preparation of the manuscript is available in the editorial manager.
The Title page should include a concise and informative title, followed by the full name(s) of the author(s); the institutional affiliation of each author; the name and address of the corresponding author (including telephone, fax and E-mail), and an abbreviated title (not exceeding 60 characters). This should be followed by the abstract page, summarizing in less than 250 words the reasons for the study, experimental approach, the major findings (with specific data if possible), and the principal conclusions, and providing 3-6 key words for indexing purposes. Structured abstracts are required. Slovene authors are requested to provide title and the abstract in Slovene language in a separate file. The text of the research article should then proceed as follows:
Introduction should summarize the rationale for the study or observation, citing only the essential references and stating the aim of the study.
Materials and methods should provide enough information to enable experiments to be repeated. New methods should be described in details.
Results should be presented clearly and concisely without repeating the data in the figures and tables. Emphasis should be on clear and precise presentation of results and their significance in relation to the aim of the investigation.
Discussion should explain the results rather than simply repeating them and interpret their significance and draw conclusions. It should discuss the results of the study in the light of previously published work.
Charts, Illustrations, Images and Tables
Charts, Illustrations, Images and Tables must be numbered and referred to in the text, with the appropriate location indicated. Charts, Illustrations and Images, provided electronically, should be of appropriate quality for good reproduction. Illustrations and charts must be vector image, created in CMYK color space, preferred font “Century Gothic”, and saved as .AI, .EPS or .PDF format. Color charts, illustrations and Images are encouraged, and are published without additional charge. Image size must be 2.000 pixels on the longer side and saved as .JPG (maximum quality) format. In Images, mask the identities of the patients. Tables should be typed double-spaced, with a descriptive title and, if appropriate, units of numerical measurements included in the column heading. The files with the figures and tables can be uploaded as separate files.
References
References must be numbered in the order in which they appear in the text and their corresponding numbers quoted in the text. Authors are responsible for the accuracy of their references. References to the Abstracts and Letters to the Editor must be identified as such. Citation of papers in preparation or submitted for publication, unpublished observations, and personal communications should not be included in the reference list. If essential, such material may be incorporated in the appropriate place in the text. References follow the style of Index Medicus, DOI number (if exists) should be included.
All authors should be listed when their number does not exceed six; when there are seven or more authors, the first six listed are followed by “et al.”. The following are some examples of references from articles, books and book chapters:
Dent RAG, Cole P. In vitro maturation of monocytes in squamous carcinoma of the lung. Br J Cancer 1981; 43: 486-95. doi: 10.1038/bjc.1981.71
Chapman S, Nakielny R. A guide to radiological procedures. London: Bailliere Tindall; 1986.
Evans R, Alexander P. Mechanisms of extracellular killing of nucleated mammalian cells by macrophages. In: Nelson DS, editor. Immunobiology of macrophage. New York: Academic Press; 1976. p. 45-74.
Authorization for the use of human subjects or experimental animals
When reporting experiments on human subjects, authors should state whether the procedures followed the Helsinki Declaration. Patients have the right to privacy; therefore, the identifying information (patient’s names, hospital unit numbers) should not be published unless it is essential. In such cases the patient’s informed consent for publication is needed, and should appear as an appropriate statement in the article. Institutional approval and Clinical Trial registration number is required. Retrospective clinical studies must be approved by the accredited Institutional Review Board/Committee for Medical Ethics or other equivalent body. These statements should appear in the Materials and methods section.
The research using animal subjects should be conducted according to the EU Directive 2010/63/EU and following the Guidelines for the welfare and use of animals in cancer research (Br J Cancer 2010; 102: 1555 – 77). Authors must state the committee approving the experiments, and must confirm that all experiments were performed in accordance with relevant regulations.
These statements should appear in the Materials and methods section (or for contributions without this section, within the main text or in the captions of relevant figures or tables).
Transfer of copyright agreement
For the publication of accepted articles, authors are required to send the License to Publish to the publisher on the address of the editorial office. A properly completed License to Publish, signed by the Corresponding Author on behalf of all the authors, must be provided for each submitted manuscript.
The articles are open-access, distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original publication in
this journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Conflict of interest
When the manuscript is submitted for publication, the authors are expected to disclose any relationship that might pose real, apparent or potential conflict of interest with respect to the results reported in that manuscript. Potential conflicts of interest include not only financial relationships but also other, non-financial relationships. In the Acknowledgement section the source of funding support should be mentioned. The Editors will make effort to ensure that conflicts of interest will not compromise the evaluation process of the submitted manuscripts; potential editors and reviewers will exempt themselves from review process when such conflict of interest exists. The statement of disclosure must be in the Cover letter accompanying the manuscript or submitted on the form available on www.icmje.org/coi_disclosure.pdf
The use and explanation of AI and AI-assisted technologies in scientific writing
When authors use artificial intelligence (AI) and AI-assisted technologies in the writing process, they should consider that:
- These technologies should only be used to improve readability and language and to assist in the investigation of data. They should not replace researchers' primary tasks of explaining, the interpretation of data and drawing valid scientific conclusions.
- Apply the technology under human supervision and control, and carefully review and edit the result, because AI can produce authoritative-sounding results that may be incorrect, incomplete, or biased.
- Do not list AI or AI-assisted technologies as authors or co-authors, and do not cite AI as an author. Authorship carries with it responsibilities and tasks that only humans can perform.
- Disclose in your manuscript the use of AI and AI-enabled technologies in the writing process by following the instructions below. An appropriate statement should appear in the published paper. Please note that authors are ultimately responsible and accountable for the content of the paper.
Disclosure notes
Authors must disclose the use of AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the main manuscript file before the bibliography, at the time of manuscript submission. The statement should be included in a new section titled 'Statement on the Use of AI and AI-Assisted Technologies in the Writing Process'.
Statement: during the preparation of this paper, the author(s) used [NAME TOOL / SERVICE] to create [REASON]. After using this tool/service, the author(s) have reviewed and edited the content as required and take full responsibility for the content of the publication.
This statement does not apply to the use of basic tools to check grammar, spelling, references, etc. If there is nothing to disclose, it is not necessary to add a statement.
Page proofs
Page proofs will be sent by E-mail to the corresponding author. It is their responsibility to check the proofs carefully and return a list of essential corrections to the editorial office within three days of receipt. Only grammatical corrections are acceptable at that time.
Open access
Papers are published electronically as open access on https://content.sciendo.com/raon,
also papers accepted for publication as E-ahead of print.
Instructions for authors - PDF
We strongly suggest you use our MS Word template for submission.
Copyright Notice
License to Publish
Please read the terms of this agreement, print, initial page 1, sign page 3, scan and send the document as one file attached to an e-mail to gsersa@onko-i.si
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.